𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 4

✍ Scribed by N. Tzaribachev; J. Kuemmerle-Deschner; M. Eichner; G. Horneff


Publisher
Springer
Year
2008
Tongue
English
Weight
209 KB
Volume
28
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long-term safety and efficacy of etanerc
✍ Daniel J. Lovell; Andreas Reiff; Olcay Y. Jones; Rayfel Schneider; James Nocton; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticular‐course juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye

Safety and efficacy of meningococcal c v
✍ Evelien Zonneveld-Huijssoon; Arash Ronaghy; Marion A. J. Van Rossum; Ger T. Rijk πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 154 KB πŸ‘ 2 views

## Abstract ## Objective To determine whether vaccinations aggravate the course of autoimmune diseases such as juvenile idiopathic arthritis (JIA) and whether the immune response to vaccinations may be hampered by immunosuppressive therapy for the underlying disease. ## Methods In this multicent